Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2026)

Fulgent Genetics has reported Other Non-Current Liabilities for 10 years, with the latest figure at $9.0 million in Q2 2026.

• Quarterly Other Non-Current Liabilities rose 51.94% year-over-year to $9.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.0 million (up 51.94% YoY) and the FY2025 annual result came in at $7.6 million, up 9.34% from the prior year.
• Other Non-Current Liabilities eased to $9.0 million in Q2 2026 per FLGT's latest filing, from $9.4 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $21.7 million in Q2 2022 and troughed at $5.9 million in Q2 2025.
• A 5-year average of $12.5 million and a median of $12.9 million in 2024 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities jumped 1792.01% in 2022, then sank 58.98% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $18.2 million in 2022, then slipped by 17.28% to $15.1 million in 2023, then tumbled by 53.77% to $7.0 million in 2024, then gained by 9.34% to $7.6 million in 2025, then grew by 17.68% to $9.0 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $9.0 million, $9.4 million, and $7.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.